BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

South Korea

Evonik Launches Global Competence Network to Advance Cell Culture-Based Therapies

First point of contact for partners seeking to manufacture cell culture-based therapies more efficiently Draws on multidisciplinary team of experts Dri...

October 03, 2024 | News

SK Bioscience Acquires IDT Biologika to Accelerate Global Growth and Dominate the CDMO Industry

- SK bioscience completed the acquisition of German CDMO company IDT Biologika with over a century of history that enables immediate expansion in revenue...

October 02, 2024 | News

Cytiva Launches State-of-the-Art Innovation Hub in South Korea, Paving the Way for Biopharma Breakthroughs in APAC

The Innovation Hub located in Songdo, Incheon will encompass a manufacturing facility together with a customer experience lab. Operations of the...

October 01, 2024 | News

SK Pharmteco Invests $260 Million in New Sejong Facility to Boost Small Molecule and Peptide Production

- Expansion includes a new 5-story, 136k sq. ft. multipurpose building in Sejong - More than 300 new employees to be hired for the anticipated 2026 ...

September 30, 2024 | News

Samsung Biologics Introduces Advanced Development Platforms to Boost Therapeutic Efficacy

Samsung Biologics showcases new innovative development platforms – S-AfuCHOTM and S-OptiChargeTM – at BioProcess International...

September 26, 2024 | News

Hyundai Bioscience Partners with UC San Diego for Pioneering Long-COVID Clinical Trial of Antiviral Xafty®

Hyundai Bioscience USA announced that it has signed an MOU with the University of California San Diego (UCSD) to conduct an invest...

September 18, 2024 | News

Hyundai Bioscience Announces XAFTY®: A Breakthrough Broad-Spectrum Antiviral for COVID-19, Mpox, and Dengue

Hyundai Bioscience presents development updates of its broad-spectrum antiviral at the "Disease Prevention and Control Summit 2024" held in Philadel...

September 12, 2024 | News

GC Cell Partners with Indonesia’s Bifarma in Major Technology Transfer for Immuncell-LC Cancer Therapy

GC Cell, a leading innovator in cell therapy, has officially announced the execution of a landmark 'Technology Transfer and License Agreement' with PT Bifa...

September 11, 2024 | News

Lunit Integrates AI Biomarker into Roche's navify® Platform, Boosting Precision in Cancer Biomarker Testing

Lunit's AI-powered biomarker, Lunit SCOPE PD-L1 TPS, integrates into Roche's navify® Digital Pathology platform to enhance precision medicine an...

September 10, 2024 | News

Neurophet Expands Global Reach with AI Brain Imaging Partnership and Research Recognition

Neurophet accelerates global expansion for research and partnership in AI-driven brain image analysis Neurophet, an artificial intelligence (AI) solution ...

September 10, 2024 | News

Seegene Launches Advanced Novaplex™ Assay to Combat High-Mortality Mpox Clade I

Introduces Novaplex™ MPXV/OPXV plus Assay (RUO) that is designed to detect Clade I, which has higher transmission and mortality rates than Cla...

September 10, 2024 | News

GC Biopharma and Hanmi Pharmaceutical Receive FDA Clearance for Phase 1/2 Trial of First Once-Monthly Subcutaneous Treatment for Fabry Disease

Co-development of innovative new drug for the treatment of Fabry disease as "the world's first once-monthly subcutaneous treatment" Improves efficacy co...

September 04, 2024 | News

Hyundai Bioscience Advances Xafty® as Sole Oral COVID-19 Treatment for High-Risk Patients Ineligible for Paxlovid®

"Xafty® can be the only oral COVID-19 treatment that can be prescribed to high-risk group patients who cannot take Paxlovid®" "While maintaining...

August 29, 2024 | News

Zuellig Pharma Secures Exclusive Distribution Agreement with Regeneron to Launch Libtayo® in South Korea and Taiwan

Zuellig Pharma, a leading healthcare solutions company in Asia, has announced an exclusive distribution agreement with Regeneron Ireland DAC, a wholly owne...

August 28, 2024 | News

Stay Connected